A Look Inside mSquared, Medrio’s Biggest Event of the Year

The stakes are high in clinical research. The results of a clinical trial can have major implications for public health, and success in those trials rests, in large part, on the assurance that data is protected, accurate, and collected rapidly. It should be obvious, then, that a major responsibility of an EDC provider is to stay closely attuned to the…

eSource Is Here: What to Do Today to Ensure Success Tomorrow

For years, EDC has allowed sponsors and CROs to make great strides toward eliminating the burdens of paper-based data management. Now eSource, by extending eClinical functionality to the site level, is on the cusp of finishing the job. This technology has brought about unprecedented efficiencies in data capture and monitoring – and with its benefits already out on the market,…

We’re Coming to Europe – and Bringing Our eClinical Philosophy With Us

It’s an exciting time at Medrio! Our presence in Europe is rapidly expanding, with new personnel in the UK, Germany, Spain, and Slovakia, and an upcoming visit to DIA Europe this April in Basel, Switzerland! If this is your first introduction to Medrio, keep reading for an overview of who we are and what we do. In addition to providing…

What Does Quality Mean in Medical Device Clinical Trials?

We’ve written a lot about the evolving nature of clinical research and the new challenges it has presented to the industry, such as increasing complexity of study designs and greater prevalence of international studies. These changes are by no means exclusive to pharma – a recent article appearing in MasterControl outlines the ways in which trends like these, as well…

A More Positive Outlook for Clinical Research in Europe

If you’re someone who keeps up with global trends in the clinical research industry, you’ve read a lot of stories over the last several years. There was the urgent search for vaccines when Ebola and Zika hit West Africa and Latin America, respectively. Precision medicine has stoked discussion of n-of-1 clinical trials taking the place of traditional models. But one…

Medrio News Roundup: January 2018

Welcome to the Medrio News Roundup, where we brief you on a sample of recent events and developments taking place around the industry. This recurring update functions on popular demand – the stories in the post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and retweets…

Optimizing the EDC Onboarding Process

Let’s say you’ve gone through a rigorous selection process to pick your EDC, deployed it, and are ready to train your staff. Your data management team encompasses a wide spectrum of EDC experience – some data managers have used EDC a lot, others very little – and their training needs therefore vary as well. But to your dismay, you discover…

The Future Looks Bright for mHealth in Clinical Trials

mHealth technology – the practice of collecting and managing medical data using phones, tablets and other mobile devices – seems poised to flood the clinical research industry like never before: Pharma companies, CROs and academics all recognize the potential of these technologies to improve clinical trials, and regulators are signaling their approval by taking action on new guidelines for their…

More Insight from MAGI 2017 West: What’s Driving Change in the Industry?

Back in November, Medrio dispatched a handful of representatives to MAGI’s Clinical Research Conference in San Francisco. The conference was full of important players in the clinical research industry, who shared fascinating observations, predictions, best practices, and more over the course of dozens of enlightening sessions. We followed up our trip a month later with a blog post on a…

The Road to a Smarter EDC Workflow

At long last, the electronic data capture (EDC) industry is showing signs of evolving beyond the challenges that stem from traditional pricing models and workflows. Here’s a scenario you may find familiar if you’re a veteran EDC user: During your vendor selection process, you’re in discussions with a company that promises a monthly subscription cost significantly lower than any of…

Monthly News Roundup: November 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

3 Insights into Medical Device Regulations from MAGI West

Back in November, MAGI’s Clinical Research Conference came to the Fairmont Hotel in San Francisco, California. Considering the wealth of insight on the agenda related to clinical trial technology, regulatory issues, and more, as well as the conference’s convenient location – Medrio’s headquarters is just about a mile down the street from the Fairmont – the decision to attend was…

Our Role in Healthcare’s Cloud Revolution

If data were absolutely crucial to the success of your business, and someone offered you a way to store, access, and analyze it that’s faster, better, and cheaper than what you’ve been doing for decades, chances are you’d switch. So it’s no surprise that healthcare-related businesses have joined the revolution and switched from on-premise IT infrastructures to cloud computing. What,…

Why Is Study Build Still Taking So Long?

The Tufts Center for the Study of Drug Development released its 2017 eClinical Landscape Study last month, and among the results is a troubling statistic: Companies conducting clinical trials are taking an average of 68 days to build their studies, with 77% of survey respondents reporting problems entering data into their electronic data capture (EDC) solution. This comes at a…

Medrio Has a New Look
A sleek image for savvy EDC users

  Medrio has evolved a great deal – and so has our image. Recent upgrades and innovations have unlocked new capabilities for our customers and enhanced the speed, intuitiveness, and efficiency that define their experience with our software. It was time to update our image to reflect the savvy and confident work our users perform every day. Our new look…

The Ultimate EDC Buyer’s Guide: Fundamentals

From self-driving cars to cancer-killing nanobots, the past decade has taken huge leaps in technological advancement, moving us closer to a world our predecessors never imagined. In the same timeframe, clinical trials have become more diverse, and the economic landscape for pharmaceuticals necessitates quicker trial timelines. These pressures have prompted an increased need for electronic data capture (EDC) systems that…

Monthly News Roundup: October 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

What EDC Means at the End of the Day

Shorter timelines, budget savings, easier data management—these are proven benefits of electronic data capture (EDC) for all phases of clinical research. Yet by continuing to use paper-based data capture, as of 2015, more than half of all new clinical trials were missing out on those benefits. That’s unfortunate – but what’s even more unfortunate is that the cost- and time-savings…

What Are the eClinical Implications of the New EU Data Regulation?

A recent article in Clinical Leader outlined concerns about Pharma’s ability to comply with the new EU Data Protection Regulation set to go into effect in May 2018. Indeed, companies doing business in the European Union will have major regulatory changes to contend with, including: Increased territorial scope, which includes where data is processed and stored Increased penalties, which can…

How a Data Management Challenge Becomes a Success Story

Clinical trials are susceptible to all kinds of unforeseen changes: protocol amendments, patient attrition – even a mid-study switch to a new EDC. This was the challenge the research consultants at Study Builders faced after the EDC originally selected by their study sponsor fell short of meeting their needs. In the midst of a time-sensitive Phase 0 study, the decision…

Immunotherapy Research: The Ups and Downs

Nearly two years after we first posted about it, immunotherapy remains one of the biggest buzz generators in clinical research and drug development. This is no surprise – the industry seems to truly believe in the potential of immunotherapy to revolutionize cancer treatment, and sees in it a largely untapped market full of territory yet to be claimed. As a…

Monthly News Roundup: August 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

3 Reasons Cybersecurity Has Become a Top Concern in Clinical Research

The intersection of technology and healthcare has major implications, ranging from encouraging to ominous, for innumerable interested parties. Technological innovators and enthusiastic adoptees tout the potential for technology to improve care and accelerate the development of new treatments and even cures – and they’re not wrong to do so. Part of this, however, is the unavoidable reality that the good…

What Can eSource Do for Patient Engagement?

Modern eClinical tools like eSource-equipped tablet apps are great for site staff and other clinical researchers. How can they help cater to the needs and priorities of clinical trial patients as well? Our infographic offers some insight. Thanks for reading! If you enjoyed this post, we invite you to check out an article we published in International Clinical Trials exploring…

Addressing Clinical Trial Infrastructure Challenges

The last several years have seen a number of high-profile disease outbreaks across the developing world. Ebola struck three West African nations in 2014, mobilizing the World Health Organization and bringing doctors from around the world to the affected areas. The following year, the Zika virus spread throughout major portions of Latin America, with significant impact reaching as far north…

Monthly News Roundup: July 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

3 Considerations as Clinical Trials Go Global

Ask an economist to name the most defining business trend of the 21st Century, and there’s a strong chance the answer will be globalization. Nations and regions are becoming increasingly intertwined through trade and outsourcing. Clinical research is no exception to this trend. Multi-country clinical trials have risen in recent years, and new regions have emerged as today’s most promising…

Monthly News Roundup: June 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

The Benefits of Integration-Ready eClinical

The growing complexity of clinical research has been met, in tandem, by an explosion of eClinical tools enabling researchers to manage that complexity. Electronic data capture (EDC) has optimized data management. Clinical trial management, a sprawling undertaking, is reined in by CTMS. Trial master files (TMF) have gone electronic. As a player in the eClinical market, Medrio is, of course,…

Monthly News Roundup: May 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

The Advantages of CRO-EDC Unity

There’s something endearing about businesses with regular customers. Personal touches, like the business knowing, by heart, things like a customer’s first name and regular order, soften the colder, more transactional nature of their relationship. Ask someone for an example of a type of business that has relationships like these, and she’ll likely cite some neighborhood-oriented establishment, like a restaurant or…

Monthly News Roundup: April 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

How Adaptive Trial-Friendly EDC Benefits Oncology

Adaptive clinical trial design in oncology research represents an intersection of two major industry trends. One of these is the current prevalence of cancer clinical trials. Last year, Clinical Leader cited a GBI Research report that declared oncology the largest therapeutic area in the pharmaceutical industry pipeline. And the promise of immunotherapy continues to galvanize investigations into new cancer treatments.…

Assessing eClinical Tools for Complex Clinical Trials

It’s a time of great evolution for clinical research. Recent years have seen a major expansion in the size and scope of industry operations. It’s increasingly common for clinical trials to cross borders, oceans, and continents.1 Studies and datasets are bigger, and protocols are more complex.2 All of this makes for a more intricate research environment than previous generations of…

Paper in Clinical Trials: No Trivial Problem

When it comes to data management in clinical trials, paper is not just an inconvenience – it’s a liability. The advent of eClinical technology is not driven solely by the discomfort of working in an office full of stacks of paper. Rather, the eClinical revolution is about data security, timelines, and budgets. The ability of CROs to meet their sponsors’…

Monthly News Roundup: March 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

3 Ways to Avoid the Hidden Costs of EDC Training and Support

It has now been several decades since EDC was first introduced as a tool for data management in clinical trials. In that time, boosted by continuous developments and enhancements, the technology has grown from a somewhat esoteric alternative to paper to a standard considered essential throughout most of the industry. Without thorough and comprehensive training and support resources, though, it…

Saving Time with an Efficient EDC Interface

Over the years, the clinical research industry has developed various methods for accessing crucial time savings. Much has been published, for example, on strategies for enhancing patient recruitment, a process that is notoriously vulnerable to delays. EDC, of course, is another major source of these savings. Range checks, for example, allow users to correct errors immediately; once data is transferred…

What Does the Chan Zuckerberg Biohub Mean for EDC?

Medical research has seen a great deal of high-profile philanthropic investment in recent years. Last year, for example, tech billionaire Sean Parker made a $250 million donation to further the development of immunotherapy. Most recently, the Chan Zuckerberg Biohub has made headlines by announcing plans to invest $3 billion in new research over the next 10 years. The investment is…

eSource from the Site Perspective

With the necessary technology and the support of the FDA in place, the eSource revolution is charging forward. Researchers are marveling at the efficiencies eSource creates as its adoption becomes more widespread. While one may expect that a new, groundbreaking technology will initially be met with some resistance from the industry it affects, eSource has already proved highly effective in…

Recent Posts